首页> 外文期刊>BMC Cancer >The role of Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis
【24h】

The role of Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis

机译:支气管内超声引导下经支气管针吸(EBUS-TBNA)在纵隔和肺门淋巴结肿大定性诊断中的作用:前瞻性分析

获取原文
           

摘要

Background Recently EBUS-TBNA, which has a sensitivity of 94.6%, specificity of 100% and diagnostic accuracy rate of 96.3% as previously reported, has been widely used for patients with mediastinal and hilar lymphadenopathy or suspected lung cancer to get accurate diagnosis. The purpose of the current study was to evaluate the usefulness of EBUS-TBNA in obtaining cytological and histological diagnosis of mediastinal and hilar lymph nodes compared to the results obtained with conventional mediastinoscopy as previously reported, and to assess the relationship of diagnostic accuracy and number of passes and size of lymph nodes. Methods 101 patients with mediastinal and hilar lymphadenopathy or suspected lung cancer in our institution were included in this prospective study. EBUS-TBNA was performed in all cases. The final diagnosis was confirmed by cytology, surgical results, and/or clinical follow-up for at least 6 months. Sensitivity, specificity, accuracy, and positive and negative predictive values were calculated using standard formulas. Results In 101 patients, EBUS-TBNA was successfully performed to obtain samples from 225 lymph nodes, 7 lung masses, 1 mediastinal mass and 2 esophageal masses. 63 malignant tumors and 38 benign diseases were confirmed. Epidermal growth factor receptor mutation was detected in 10 biopsy samples, and epidermal growth factor receptor mutation was detected in 4 cases. With respect to the correct diagnosis of mediastinal and hilar lymphadenopathy, EBUS-TBNA had a sensitivity of 95.08%, specificity of 100%, positive predictive value of 100%, negative predictive value of 93.02%, and overall accuracy of 97.02%. The relationship of diagnostic accuracy and number of lymph node passes or size of lymph nodes was both insignificant (p = 0.27; p = 0.23). The procedure was uneventful without complications. Conclusions EBUS-TBNA is an accurate and safe tool in diagnosis of mediastinal and hilar lymphadenopathy. It cannot completely replace mediastinoscopy, it may indeed reduce the number of mediastinoscopy procedures. In some cases, it can necessarily be the first-line procedure before mediastinoscopy.
机译:背景技术最近,EBUS-TBNA的敏感性为94.6%,特异性为100%,诊断准确率为96.3%,如先前报道的那样,已广泛用于纵隔和肺门淋巴结病或疑似肺癌的患者,以进行准确的诊断。本研究的目的是评估EBUS-TBNA在获得纵隔和肺门淋巴结细胞学和组织学诊断方面的有效性,与以前报道的传统纵隔镜检查结果进行比较,并评估诊断准确性与数量的关系。通过和淋巴结的大小。方法将本院101例纵隔和肺门淋巴结病或疑似肺癌患者纳入研究。在所有情况下均进行EBUS-TBNA。细胞学检查,手术结果和/或至少6个月的临床随访证实了最终诊断。使用标准公式计算灵敏度,特异性,准确性以及阳性和阴性预测值。结果在101例患者中,成功进行了EBUS-TBNA检查,获得了225个淋巴结,7个肺肿块,1个纵隔肿块和2个食道肿块。确认63例恶性肿瘤和38例良性疾病。在10份活检样本中检测到表皮生长因子受体突变,在4例中检测到表皮生长因子受体突变。对于纵隔和肺门淋巴结病的正确诊断,EBUS-TBNA的敏感性为95.08%,特异性为100%,阳性预测值为100%,阴性预测值为93.02%,总体准确性为97.02%。诊断准确性与淋巴结通过次数或淋巴结大小的关系均不显着(p = 0.27; p = 0.23)。程序顺利,无并发症。结论EBUS-TBNA是诊断纵隔和肺门淋巴结病的准确,安全的工具。它不能完全取代纵隔镜检查,它的确可以减少纵隔镜检查程序的数量。在某些情况下,它可能必须是纵隔镜检查之前的一线手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号